{"id":967357,"date":"2026-05-27T08:06:15","date_gmt":"2026-05-27T12:06:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/"},"modified":"2026-05-27T08:06:15","modified_gmt":"2026-05-27T12:06:15","slug":"aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/","title":{"rendered":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, May  27, 2026  (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (\u201cAldeyra\u201d) (NASDAQ: ALDX). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts regarding Aldeyra\u2019s business, operations, and prospects, including allegations that: (1) the results of the reproxalap clinical trials were inconsistent; and (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful.<\/p>\n<p align=\"justify\">If you purchased Aldeyra shares between <strong>November 3, 2023 and March 16, 2026<\/strong>,\u00a0and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SEwHyucs0lZBtn8cu7Wtv91HjSr1oBmFWjFgqliAbY7ywCKJxCct-OnZgPrZGBf1Qanq_JE_Uo-Bi-uKKEy7WpncxiBNmP1F6ToSeMNe48s=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_AG0y64-nHy0XkcRC1nLJjoyNWx9fIQ-ptlWLxHHnLn3thAF3Fm90xp09IGZbYTPYSF1NqvUPSyHhxN4CiqPzceEBSRYr_WD_fisQBqIwFl-TtYecYA-wuBiNHiM0LSyyLgHfQ9GOJNZV2CNPykA1tQQGkbymJr_bBla78aRNiM=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/aldeyra-therapeutics\/<\/a> for more information.\u00a0<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is May 29, 2026.\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202fwww.holzerlaw.com,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.\u00a0<br \/>(888) 508-6832 (toll-free)<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SEwHyucs0lZBtn8cu7Wtv91HjSr1oBmFWjFgqliAbY6nlqfQW1oC5TIr1AnOk5wsb0xw7GphPDsW5Y3bo9LcTZwp90vPnVD26klaANMwPwc=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Yzg3MDEwOGYtYTZkOS00Y2VlLWEyN2YtNTAxNGZlMTYwOTIzLTExOTIzMzYtMjAyNi0wNS0yNy1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, May 27, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (\u201cAldeyra\u201d) (NASDAQ: ALDX). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts regarding Aldeyra\u2019s business, operations, and prospects, including allegations that: (1) the results of the reproxalap clinical trials were inconsistent; and (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful. If you purchased Aldeyra shares between November 3, 2023 and March 16, 2026,\u00a0and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967357","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, May 27, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (\u201cAldeyra\u201d) (NASDAQ: ALDX). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts regarding Aldeyra\u2019s business, operations, and prospects, including allegations that: (1) the results of the reproxalap clinical trials were inconsistent; and (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful. If you purchased Aldeyra shares between November 3, 2023 and March 16, 2026,\u00a0and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by &hellip; Continue reading &quot;ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T12:06:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action\",\"datePublished\":\"2026-05-27T12:06:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/\",\"name\":\"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\",\"datePublished\":\"2026-05-27T12:06:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/","og_locale":"en_US","og_type":"article","og_title":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk","og_description":"ATLANTA, May 27, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (\u201cAldeyra\u201d) (NASDAQ: ALDX). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts regarding Aldeyra\u2019s business, operations, and prospects, including allegations that: (1) the results of the reproxalap clinical trials were inconsistent; and (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful. If you purchased Aldeyra shares between November 3, 2023 and March 16, 2026,\u00a0and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by &hellip; Continue reading \"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-27T12:06:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action","datePublished":"2026-05-27T12:06:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/","name":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=","datePublished":"2026-05-27T12:06:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjk3NiM3NjIyMzY5IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-investor-alert-holzer-holzer-llc-reminds-investors-of-the-may-29-2026-lead-plaintiff-deadline-in-the-aldeyra-therapeutics-inc-securities-class-action\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALDX INVESTOR ALERT: Holzer &amp; Holzer, LLC Reminds Investors of the May 29, 2026 Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Securities Class Action"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967357"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967357\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}